These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38386617)

  • 1. Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study.
    Dong X; Du L; Luo Z; Xu Y; Wang C; Wang F; Cao W; Zhao L; Zheng Y; Zhu H; Xia C; Li J; Du M; Hang D; Ren J; Shi J; Shen H; Chen W; Li N; He J;
    PLoS Med; 2024 Feb; 21(2):e1004340. PubMed ID: 38386617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 3. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
    González-López N; Quintero E; Gimeno-Garcia AZ; Bujanda L; Banales J; Cubiella J; Salve-Bouzo M; Herrero-Rivas JM; Cid-Delgado E; Alvarez-Sanchez V; Ledo-Rodríguez A; de-Castro-Parga ML; Fernández-Poceiro R; Sanromán-Álvarez L; Santiago-Garcia J; Herreros-de-Tejada A; Ocaña-Bombardo T; Balaguer F; Rodríguez-Soler M; Jover R; Ponce M; Alvarez-Urturi C; Bessa X; Roncales MP; Sopeña F; Lanas A; Nicolás-Pérez D; Adrián-de-Ganzo Z; Carrillo-Palau M; González-Dávila E;
    PLoS Med; 2023 Oct; 20(10):e1004298. PubMed ID: 37874831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps.
    Zorzi M; Battagello J; Amidei CB; Antonelli G; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rizzotto ER; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rugge M; ; Hassan C
    Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1518-1527.e7. PubMed ID: 38325601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing colorectal cancer screening in high-risk population through fecal immunochemical test surveillance: Results from a surveillance program.
    Qin H; Zhang M; Zhang G; Zhao L; Zhang H; Zhang W; Wang Y; Zhang X; Xie L; Qian B
    Cancer Med; 2024 Oct; 13(20):e70145. PubMed ID: 39428708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants.
    Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB
    BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai, China.
    Gong Y; Peng P; Bao P; Zhong W; Shi Y; Gu K; Zheng Y; Wu C; Cai S; Xu Y; Sheng J; Wu F
    Oncologist; 2018 Aug; 23(8):928-935. PubMed ID: 29540604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining FITs and HRFQ with colonoscopy improve the cost-effectiveness of a 9-year mass colorectal cancer screening program.
    Cai SR; Huang YQ; Li QR; Zhu HH; Zhang SZ; Song YM; Yang JH; Zheng S
    ESMO Open; 2024 Sep; 9(9):103676. PubMed ID: 39168026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
    Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M
    Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
    Ykema BLM; Bisseling TM; Spaander MCW; Moons LMG; van der Biessen-van Beek D; Saveur L; Kerst M; Mulder SF; de Wit R; Zweers D; Meijer GA; Beijnen JH; Lansdorp-Vogelaar I; van Leeuwen FE; Snaebjornsson P; van Leerdam ME
    BMC Gastroenterol; 2021 Feb; 21(1):67. PubMed ID: 33579196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
    Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
    [No Abstract]   [Full Text] [Related]  

  • 19. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.